Search research articles
Contact Us
Filters
Showing results (371-380 of 413) with videos related to
Page
of 42
Sort By:
The Prostate
|
February 17, 2015
Safety of enzalutamide in patients with metastatic castration-resistant prostate cancer previously treated with docetaxel: expanded access in North America
Anthony M Joshua, Neal D Shore, Fred Saad, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 17, 2015
Improvements in Radiographic Progression-Free Survival Stratified by ERG Gene Status in Metastatic Castration-Resistant Prostate Cancer Patients Treated with Abiraterone Acetate
Gerhardt Attard, Johann S de Bono, Christopher J Logothetis, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada
|
April 9, 2020
Prioritizing systemic therapies for genitourinary malignancies: Canadian recommendations during the COVID-19 pandemic
Aly-Khan A Lalani, Kim N Chi, Daniel Y C Heng, et al.
Cancer Immunology Research
|
September 9, 2016
Tn-MUC1 DC Vaccination of Rhesus Macaques and a Phase I/II Trial in Patients with Nonmetastatic Castrate-Resistant Prostate Cancer
Elizabeth Scheid, Pierre Major, Alain Bergeron, et al.
JAMA Oncology
|
September 17, 2020
Efficacy and Safety of nab-Paclitaxel vs Paclitaxel on Survival in Patients With Platinum-Refractory Metastatic Urothelial Cancer: The Canadian Cancer Trials Group BL.12 Randomized Clinical Trial
Srikala S Sridhar, Normand Blais, Ben Tran, et al.
Current Oncology (Toronto, Ont.)
|
April 26, 2024
Access to Oncology Medicines in Canada: Consensus Forum for Recommendations for Improvement
Sandeep R Sehdev, Nigel S B Rawson, Olexiy I Aseyev, et al.
Breast Cancer Research and Treatment
|
April 28, 2017
Effects of metformin versus placebo on vitamin B12 metabolism in non-diabetic breast cancer patients in CCTG MA.32
Ana Elisa Lohmann, Mira F Liebman, William Brien, et al.
Diabetes
|
December 4, 2021
Functional Gly297Ser Variant of the Physiological Dysglycemic Peptide Pancreastatin Is a Novel Risk Factor for Cardiometabolic Disorders
Prasanna K R Allu, Malapaka Kiranmayi, Sromona D Mukherjee, et al.
Journal of the National Cancer Institute
|
March 6, 2015
Effect of metformin vs placebo on and metabolic factors in NCIC CTG MA.32
Pamela J Goodwin, Wendy R Parulekar, Karen A Gelmon, et al.
The Journal of Urology
|
January 3, 2022
Low Serum Testosterone in Men with Newly Diagnosed Androgen-Deprivation Therapy-Naïve Prostate Cancer and Its Relationship to Cardiovascular Risk Factors: A RADICAL-PC Substudy
Jehonathan H Pinthus, Wilhelmina C M Duivenvoorden, Laurence Klotz, et al.
Page
of 42
Search research articles
Search
Showing results (371-380 of 413) with videos related to
Sort By:
Page
of 42
The Prostate
|
February 17, 2015
Safety of enzalutamide in patients with metastatic castration-resistant prostate cancer previously treated with docetaxel: expanded access in North America
Anthony M Joshua, Neal D Shore, Fred Saad, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 17, 2015
Improvements in Radiographic Progression-Free Survival Stratified by ERG Gene Status in Metastatic Castration-Resistant Prostate Cancer Patients Treated with Abiraterone Acetate
Gerhardt Attard, Johann S de Bono, Christopher J Logothetis, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada
|
April 9, 2020
Prioritizing systemic therapies for genitourinary malignancies: Canadian recommendations during the COVID-19 pandemic
Aly-Khan A Lalani, Kim N Chi, Daniel Y C Heng, et al.
Cancer Immunology Research
|
September 9, 2016
Tn-MUC1 DC Vaccination of Rhesus Macaques and a Phase I/II Trial in Patients with Nonmetastatic Castrate-Resistant Prostate Cancer
Elizabeth Scheid, Pierre Major, Alain Bergeron, et al.
JAMA Oncology
|
September 17, 2020
Efficacy and Safety of nab-Paclitaxel vs Paclitaxel on Survival in Patients With Platinum-Refractory Metastatic Urothelial Cancer: The Canadian Cancer Trials Group BL.12 Randomized Clinical Trial
Srikala S Sridhar, Normand Blais, Ben Tran, et al.
Current Oncology (Toronto, Ont.)
|
April 26, 2024
Access to Oncology Medicines in Canada: Consensus Forum for Recommendations for Improvement
Sandeep R Sehdev, Nigel S B Rawson, Olexiy I Aseyev, et al.
Breast Cancer Research and Treatment
|
April 28, 2017
Effects of metformin versus placebo on vitamin B12 metabolism in non-diabetic breast cancer patients in CCTG MA.32
Ana Elisa Lohmann, Mira F Liebman, William Brien, et al.
Diabetes
|
December 4, 2021
Functional Gly297Ser Variant of the Physiological Dysglycemic Peptide Pancreastatin Is a Novel Risk Factor for Cardiometabolic Disorders
Prasanna K R Allu, Malapaka Kiranmayi, Sromona D Mukherjee, et al.
Journal of the National Cancer Institute
|
March 6, 2015
Effect of metformin vs placebo on and metabolic factors in NCIC CTG MA.32
Pamela J Goodwin, Wendy R Parulekar, Karen A Gelmon, et al.
The Journal of Urology
|
January 3, 2022
Low Serum Testosterone in Men with Newly Diagnosed Androgen-Deprivation Therapy-Naïve Prostate Cancer and Its Relationship to Cardiovascular Risk Factors: A RADICAL-PC Substudy
Jehonathan H Pinthus, Wilhelmina C M Duivenvoorden, Laurence Klotz, et al.
Page
of 42